Kenneth Mayer, MD
Professor, RST
The Miriam Hospital
Dr. Kenneth H. Mayer is a Professor of Medicine & Community Health at Brown University, the Director of the Brown University AIDS Program, and an Attending Physician in the Division of Infectious Diseases at The Miriam Hospital (Providence, R.I.). He is also the Medical Research Director of the Fenway Community Health Center in Boston where he has conducted studies of the natural history and transmission of HIV since 1983. While doing his fellowship in Infectious Diseases at Harvard Medical School at the Brigham & Women's Hospital, Dr. Mayer was one of the first clinical researchers in Boston to see patients with AIDS and HIV infection. He also is an Adjunct Professor in the Department of Immunology and Infectious Diseases at the Harvard School of Public Health.
Dr. Mayer has also been the Principal Investigator of one of the first National Institute of Allergy and Infectious Diseases-funded studies of the heterosexual transmission of HIV(starting in 1987) called the New England Behavioral Health Study. He has been a Co-Principal Investigator of the Centers for Disease Control-funded HIV Epidemiology Research Study (HERS) of the natural history of HIV in women, and has been the Principal Investigator of the New England Vaccine Preparedness Cohort studies of the National Institutes of Health's national HIV vaccine field trial effort, known as HIVNET nationally, and as Project Achieve locally. He is currently the Principal Investigator of one of the NIH's HIV Prevention Trials Units (HPTU), which is conducting studies in Boston, Providence and India, and is the co-Principal Investigator of the New England unit of the NIH's Vaccine Trials Network (HVTN). He is the Director of the Brown-Tufts Fogarty AIDS International Training and Research Program, funded by the NIH to provide training for East Asian clinical, laboratory and behavioral investigators. He is the Director of the Prevention Sciences Core of the Lifespan-Tufts-Brown Center for AIDS Research.
In 1983, Dr. Mayer co-authored one of the first books about AIDS for the general public, The AIDS Fact Book. Dr. Mayer has collaborated with other researchers to define the seroepidemiology and early spread of HIV in Boston and to assess the spread and impact of HIV in both homosexual and heterosexual communities, in New England and in Asia. Dr. Mayer has also collaborated with basic virologists and immunologists to further characterize the virology and immunopathology of HIV disease. He has been a co-investigator in early clinical studies of several antiretroviral compounds. He has been on the National Board of Directors of the American Foundation for AIDS Research, the Gay and Lesbian Medical Association, and the HIV Medicine Association (HIVMA), and served on the Data Safety, and Monitoring Board of the National Institutes of Health's AIDS Clinical Trials Group. He is on several editorial boards, and is Special Topics Editor for HIV/AIDS for Clinical Infectious Diseases. He has published more than 200 articles in the Infectious Disease literature, primarily on topics concerning the natural history, behavioral epidemiology, transmission variables, and public policy aspects of the AIDS epidemic. Most recently, Dr. Mayer co-edited The Emergence of AIDS: Impact on Immunology, Microbiology and Public Health, published by the American Public Health Association Press (2000). His work has been recognized with a citation by the Governor of Massachusetts (1986); the Rhode Island HIV Prevention Community Planning Group (1999); and the Rhode Island Department of Health (2001).
Selected Publications
- Mayer KH, Stoddard A, McCusker J, Ayotte D, Ferriani R, Groopman J: Human T-Lymphotropic Virus Type III in high risk, antibody-negative homosexual men. Annals of Internal Medicine 104:194-196, 1986.
- Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L: Persistence of Human Immunodeficiency Virus in Semen After Adding Indinavir to Combination Antiretroviral Therapy. Clinical Infectious Diseases 28:1252-9, 1999.
- Gross M, Holte S, Seage G, Buchbinder SP, Metzger DS, Mayer, KH: Feasibility of Chemoprophylaxis Studies in High Risk HIV-Seronegative Populations. AIDS Education and Prevention 12(1):71-78, 2000.
- Mayer KH, Kwong J, Singal R, Boswell S: Non-occupational post-exposure prophylaxis: Clinical issues and public health questions. Medicine and Health/Rhode Island 83:210-213, 2000.
- Mayer KH, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg: Safety and Tolerability of BufferGel, a Novel Vaginal Microbicide, in Women in the United States: Clinical Infectious Disease 32:476-482, 2001.
- Stone VE, Mansourati FF, Poses RM, Mayer KH. Relation of Physician Specialty and HIV/AIDS Experience to Choice of Guideline Recommended Antiretroviral Therapy. Journal of General Internal Medicine, 16:360-368, 2001.
- Solomon SS, Solomon S, Rodriguez II, McGarvey ST, Ganesh AK, Thyagarajan SP, Mahajan AP, Mayer, KH: Dried blood spots (DBS): a valuable tool for HIV surveillance in developing/tropical countries. International Jounal of STD & AIDS 13(1):25-28, 2002.
- Clarke JG, Peipert JF, Hilliar SL, Heber W, Boardman L, Moench TR, Mayer K: Microflora Changes with the Use of a Vaginal Microbicide. Sexually Transmitted Diseases 29(5):288-293, 2002.
- Kumarasamy N, Solomon S, Flanigan T, Hemalatha R, Thyagarajan SP, Mayer K. Natural History of HIV Disease in Southern India. Clin Inf Dis 36(1):79-85, 2003.
- Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, Day J, Welch J, Rosenberg Z, for the HIV Prevention Trials Network (HPTN) 020 Protocol Team. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS 17(3):321-329, 2003.
|